Objectives: Metastatic neoplasms in bone marrow material are rarely encountered in clinical practice. The majority of the literature is limited to case reports. The aim of the study was to assess the frequency and the clinicopathological features of metastatic neoplasms in the bone marrow. Methods: We searched our files from 1995 to 2016 for metastatic neoplasms in the bone marrow and reviewed corresponding charts for demographic and clinical features. Results: Sixty-seven cases were retrieved, 44 women and 23 men. The mean age was 60.45 years (range 26-90). Thirty-six of 67 (54%) were breast carcinoma, 12/67 (18%) prostatic carcinoma, four non-small cell lung carcinoma, two small cell carcinoma, two neuroendocrine, and one case each anaplastic thyroid, colonic, thymic, ovarian, pancreatic and urothelial carcinomas, as well as one case each large cell carcinoma with neuroendocrine features, melanoma, Ewing sarcoma, adenocarcinoma of unknown primary, and a mesenchymal tumor. Among 58 cases whose medical charts were available, 35 had a history of breast carcinoma, 11 prostate carcinoma, six lung carcinoma, and one case each had colon, ovarian, thyroid urothelial carcinoma, and melanoma. Of 29 cases of breast carcinoma with a prior diagnosis, 14 were lobular, 10 ductal, and five mixed ductal and lobular type. Bone marrow involvement was the first presentation in six patients (9%). Eight (12%) had a coexistent hematologic neoplasm: three acute myeloid leukemia, two chronic lymphocytic leukemia, two multiple myeloma, and one myelodysplastic syndrome. Blood count abnormalities were seen in 51/57 patients (89.5%) with available blood counts. Conclusion: Both epithelial and mesenchymal neoplasms metastasize to the bone marrow and can be associated with hematologic neoplasms. Lobular carcinoma of the breast is the most common metastatic neoplasm in our data. The majority of patients presented with an abnormal blood count. 
Objectives: Carcinosarcomas are high-grade tumors of the female genital tract with both malignant epithelial and mesenchymal components with few good treatment options. Tumor-infiltrating regulatory Foxp3-positive T cells have been shown to be associated with poor prognosis in various cancers. Foxp3 expression by tumor cells also modulates the immune response to the tumor with poor prognostic implications. Here we enumerated Foxp3-positive tumor-infiltrating lymphocytes (TILs) in uterine carcinosarcoma (UCS) and evaluated Foxp3 expression in tumor cells to explore their prognostic significance. Methods: Twenty-two cases of UCS were retrieved and re-evaluated. Medical charts were reviewed for overall survival (OS). Representative slides with both neoplastic components were stained for 
